PHIO
PHIO
NASDAQ · Biotechnology

Phio Pharmaceuticals Corp

$1.03
+0.02 (+1.98%)
As of Sep 29, 10:26 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +3,066.0% upside
Low Target $25.28
Average Target $32.61
High Target $46.79
Current Price $1.03
Current
$1.03
Target
$32.61
$25.28 $32.61 avg $46.79
Scenario Analysis
Bear Case
$25.28
2,354.4%
Low target
Base Case
$32.61
+3,066.0%
Avg target
Bull Case
$46.79
+4,442.7%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$4.19
-75.4% from high
52-Week Low
$0.81
+26.7% from low
Target vs 52W High
$32.61
+678.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.2%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.9%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +139.7%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.8%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -26.5%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.5%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.2%